These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35787294)

  • 1. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
    Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
    Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
    Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
    FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 and PINK1 mediate CHCHD10
    Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
    Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
    Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
    Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
    Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD10
    Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
    Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
    Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
    Xu YF; Prudencio M; Hubbard JM; Tong J; Whitelaw EC; Jansen-West K; Stetler C; Cao X; Song J; Zhang YJ
    PLoS One; 2013; 8(7):e69864. PubMed ID: 23922830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
    Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
    Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
    Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
    Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
    Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
    Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
    Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
    Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
    van Hummel A; Sabale M; Przybyla M; van der Hoven J; Chan G; Feiten AF; Chung RS; Ittner LM; Ke YD
    Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12902. PubMed ID: 36951214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.